Novartis Extends Triaminic Into Brand Name Void Left By J&J Tylenol Recall

Novartis expedites a Triaminic line extension to take advantage of the branded product gap left by the recall of Johnson & Johnson's Children's Tylenol liquid OTCs

More from Archive

More from Pink Sheet